A.P. Pharma raises $4.5 million, names new CEO

Tuesday, April 26, 2011 11:58 AM

California-based A.P. Pharma has raised $4.5 million in convertible notes and named a new CEO, according to Silicon Valley/San Jose Business Journal.  The specialty pharmaceutical company's lead drug candidate is designed to prevent acute-onset and delayed-onset chemotherapy-induced nausea and vomiting.

The private placement is through agreements with investors, including Tang Capital Partners LP.  At the closing, an amount of $1.5 million will be funded to the company and used directly to help resubmit the company's New Drug Application to the FDA. The $3 million that remains will be funded to the company at the investors’ discretion.

The company has also named John B. Whelan as president, chief executive officer and a director. Whelan has worked for A.P. Pharma since February 2009, most recently serving as acting chief executive officer and chief financial officer.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs